August 27, 2021
1 Min Read
Sponsored by PendoTECH
Biopharmaceutical manufacturing is evolving with the progression of Industry 4.0. Industry 4.0 refers to the ongoing “fourth industrial revolution,” which is transforming modern manufacturing and production practices through the use of “smart” technology. This is appealing especially to the biopharmaceutical industry, where production can be a long, meticulous, complex process, and optimizing manufacturing procedures is critical for success. As a leading supplier of single-use technology for the biopharmaceutical industry, PendoTECH recently has explored how its products can be integrated easily with an industrial platform and the opportunities that result.
At the heart of the technology that enables PendoTECH sensors and instrumentation to be adapted conveniently to a digital highway is an intelligent automation platform (IAP). Typically, an IAP has analog inputs and digital inputs/outputs for communicating with all unit-operation devices essential to manufacturing (e.g., sensors, transmitters, and monitors). The intelligent automation platform then uses its industrial communication capabilities (e.g., Ethernet, WiFi, and RS485) to communicate with a centralized controller in the required language (e.g., MODBUS, PROFIBUS, and OPC UA). That provides flexibility for a manufacturing facility to enable the correct equipment to be used when and where it is needed.
Fill out the form below to read the complete capabilities review now.
Andelyn to make viral vectors in FDA-NIH led gene therapy consortiumMar 1, 2024|1 Min Read
GLP-1 drug demand drives $250m fill/finish expansion for SimtraMar 1, 2024|3 Min Read
AstraZeneca to build global strategic center in ShanghaiMar 1, 2024|3 Min Read
Ins & Outs: Gonzalez but not forgotten at AbbVieFeb 29, 2024|2 Min Read
Mar 11 - Mar 14, 2024
Mar 11 - Mar 14, 2024
Accelerate speed to market for your next generation mAbs, vaccines, cell therapy, and gene therapy products. At the BioProcess International US West event in San Diego, CA, in March 2024 you can access today's innovative strategies and technologies designed to improve process efficiencies and maintain product quality across all phases of bioprocessing.Agenda